Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 18.38B | 18.38B | 19.85B | 21.66B | 18.26B | 14.78B |
Gross Profit | 4.76B | 14.23B | 14.55B | 13.04B | 12.16B | 12.40B |
EBITDA | 7.27B | 7.63B | 6.83B | 6.91B | 6.27B | 3.89B |
Net Income | 2.90B | 2.90B | 2.29B | 7.80B | 2.35B | 1.64B |
Balance Sheet | ||||||
Total Assets | 106.74B | 106.74B | 98.33B | 92.70B | 94.86B | 67.22B |
Cash, Cash Equivalents and Short-Term Investments | 6.93B | 6.93B | 4.25B | 2.77B | 3.35B | 2.50B |
Total Debt | 48.36B | 48.36B | 47.07B | 42.98B | 45.47B | 31.22B |
Total Liabilities | 68.92B | 68.92B | 68.43B | 63.13B | 71.00B | 47.36B |
Stockholders Equity | 37.80B | 37.80B | 29.87B | 29.54B | 23.83B | 19.84B |
Cash Flow | ||||||
Free Cash Flow | -2.74B | -2.50B | -514.00M | 6.00M | 728.00M | -327.00M |
Operating Cash Flow | 6.04B | 6.81B | 6.94B | 6.90B | 6.27B | 4.46B |
Investing Cash Flow | -10.80B | -10.57B | -7.50B | 240.00M | -14.01B | -5.12B |
Financing Cash Flow | 5.53B | 4.53B | 987.00M | -7.17B | 7.77B | 750.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
72 Outperform | £50.13B | 16.39 | 8.35% | 4.58% | -7.42% | 5.84% | |
69 Neutral | £17.76B | 14.92 | 12.29% | 3.96% | -3.11% | -31.10% | |
66 Neutral | $17.25B | 17.87 | 5.54% | 3.65% | 6.63% | 11.55% | |
61 Neutral | £7.56B | 28.34 | 13.05% | 4.68% | 10.04% | ― | |
60 Neutral | £7.48B | 32.46 | 12.73% | 4.84% | 3.78% | 50.18% | |
56 Neutral | £7.32B | 6.18 | -5.95% | 2.65% | -4.82% | -123.58% | |
― | £144.04M | 1.28 | 6.25% | ― | ― |